Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Myomo (MYO) over the last 5 years, with Q3 2025 value amounting to -$0.09.
- Myomo's EPS (Weighted Average and Diluted) fell 20000.0% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.28, marking a year-over-year decrease of 2173.91%. This contributed to the annual value of -$0.19 for FY2024, which is 3668.78% up from last year.
- Myomo's EPS (Weighted Average and Diluted) amounted to -$0.09 in Q3 2025, which was down 20000.0% from -$0.11 recorded in Q2 2025.
- In the past 5 years, Myomo's EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q2 2024 and a low of -$0.51 during Q4 2021
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.2, with a median of -$0.11 in 2023.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 9047.62% in 2023, then crashed by 26666.67% in 2025.
- Myomo's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.51 in 2021, then skyrocketed by 34.71% to -$0.33 in 2022, then skyrocketed by 67.57% to -$0.11 in 2023, then surged by 68.93% to -$0.03 in 2024, then plummeted by 168.27% to -$0.09 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.09 in Q3 2025, compared to -$0.11 in Q2 2025 and -$0.08 in Q1 2025.